After phase 3 fail, Biogen posts 12-month data cut to make case for ALS prospect
https://www.fiercebiotech.com/biotech/after-phase-3-fail-biogen-posts-12-month-data-make-case-als-prospect
Medical Innovation Exchange @ Copywrite 2021. All Rights Reserved.